NCI s $35M RFA to Create Cancer Genome Centers Could Benefit Drug Makers, Molecular Dx Shops | GenomeWeb

The US National Cancer Institute this week said that it will provide $35 million over three years to support as many as four Cancer Genome Characterization Centers. Approximately $11.7 million will be allotted this year, according to the NCI's request for applications.

The centers, part of the Cancer Genome Atlas project, should be a major source of public cancer data that may provide the basis for future targeted cancer drugs, diagnostics, and combination products.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.